Drug Trial Radar · NCT02612272
Comparing Intra-articular Corticosteroid to Intra-articular Ketorolac Knee Injections
Last checked: Nov 20, 2026Latest source record: Oct 13, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
448
Planned (sponsor's estimate)
Start
Nov 2015
Primary completion
Oct 2017
Study completion Oct 2017
Sponsor
- Lead sponsor
- St. Luke's Hospital, PennsylvaniaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 23, 2015
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will compare the efficacy of intra-articular betamethasone injection to intra-articular ketorolac injection for symptomatic treatment of knee osteoarthritis in an equivalence study using a double-blinded, randomized, controlled design. Patients will be recruited from orthopaedic clinics at St. Luke's University Health Network. A total of 448 patients will be recruited (224 in each group) to receive an administration of an intra-articular betamethasone or ketorolac injection. The primary outcome is change in pain as assessed by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score. Secondary outcomes include Knee Injury and Osteoarthritis Outcome (KOOS) and Knee Outcome Survey - Activities of Daily Living (KOS-ADL) scores and physical exam findings. Statistical analyses include repeated measures analysis of variance (ANOVA) (primary outcome) and selected ANOVA and nonparametric tests as deemed appropriate (secondary outcomes), with p \< .05 denoting significance for all comparisons, and no adjustment for multiple testing.
Conditions
- Knee Osteoarthritis
Interventions
KetorolacDrug
intra-articular ketorolac
BetamethasoneDrug
intra-articular betamethasone
Primary outcomes
What the sponsor says the trial is designed to measure.
- Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)Time frame: Follow up at 1 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
St Luke's Health and University Network
Bethlehem, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.